A detailed history of Kestra Advisory Services, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 23,640 shares of CDXC stock, worth $129,783. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,640
Previous 21,000 12.57%
Holding current value
$129,783
Previous $57,000 50.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.51 - $3.8 $6,626 - $10,032
2,640 Added 12.57%
23,640 $86,000
Q3 2022

Nov 01, 2022

SELL
$1.19 - $2.06 $2,856 - $4,944
-2,400 Reduced 10.26%
21,000 $26 Million
Q2 2022

Aug 12, 2022

BUY
$1.59 - $2.7 $3,816 - $6,480
2,400 Added 11.43%
23,400 $39,000
Q1 2021

May 10, 2021

SELL
$4.59 - $18.74 $278,920 - $1.14 Million
-60,767 Reduced 74.32%
21,000 $196,000
Q4 2020

Jan 20, 2021

BUY
$3.93 - $5.5 $321,344 - $449,718
81,767 New
81,767 $397 Million

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.